Dr. Matthew Anderson is a higher scientist within the Engineering Biology (EngBio) team at NPL, as part of the Biometrology Group; his work focuses on DNA and peptide synthesis applications to engineering biology, alongside mass spectrometry (QToF and Orbitrap) and isothermal titration calorimetry (ITC).
Trained as a medicinal chemist, Matt undertook undergraduate studies at the University of Cambridge, obtaining a master’s degree in 2020 in the group of the late Prof. Chris Abell, regarding fragment-based drug discovery (FBDD). He then conducted his PhD at Newcastle University under Profs. Mike Waring and Akane Kawamura, particularly concerning DNA-encoded libraries (DELs) and peptidomimetics, specifically peptoids. Matt completed his research studies in 2024, prior to joining NPL at the beginning of 2025.